Belgian Court Overturns Parallel Export Ban
The Prohibition Contravened EU Rules
A ban on the parallel exporting of medicines from Belgium did not achieve the desired objective of preventing drug shortages, and was also against EU rules, the Constitutional Court has ruled.
You may also be interested in...
A public health advocacy group in the EU has issued tangible recommendations to address the perennial problem of drug shortages in the region.
There are now 31 medicines on the UK’s list of products that cannot be parallel exported to other European Economic Area countries as part of government efforts to tackle drug shortages. The parallel trade industry has attacked the initiative for lack of transparency.
The French government’s plans for more price cuts and new obligations on manufacturers to avert drug shortages will add another layer of complexity to an already complicated operating environment, says the industry.